Sorry for interrupting, this website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Learn more
Accept & Close

Cold, Flu and Allergy Remedies - US - May 2011

This report builds on the analysis presented in Mintel’s Cough, Cold and Sore Throat Remedies—U.S., May 2009, as well as Cold, Flu, and Allergy Remedies—U.S., October 2007, and the 2005 and 2002 reports of the same title.

For the purposes of this report, Mintel defines the market as including all cold, flu, and allergy remedies, including decongestants, which can be purchased over the counter without a prescription and are for the symptomatic relief of colds, flu, and allergies. Each category is defined as:

  • Cold, flu, and allergy remedies: Includes all formulations, tablets, capsules, liquids, powders, and hot drinks for the treatment of a combination of cold and/or allergy symptoms or those designed for the treatment of specific symptoms associated with the common cold, flu and/or allergies (ie, cough, runny nose, itchy eyes, pain, fever).
  • Decongestants: Includes all tablets, topical and nasal sprays, rubs and inhalants to relieve nasal and chest congestion. Lozenges and medicated sweets, products for the relief of coughs and sore throats are not included in this report.

What you get

What's included

Why buy from us?

Succeed

Our reports will provide you with market data, consumer research and competitive intelligence to succeed in your market.

Instant Access

Buy now and you'll have instant access to the information you need to make the right decisions.

Opportunities

Find out what's next in the markets that matter to you: where opportunities lie and what challenges you will face.

Trusted

A business Superbrand, Mintel is a source you can trust. We have been defining and refining the Market Intelligence mix since 1972.

Table of contents

  1. Scope and Themes

    • What you need to know
      • Definition
        • Data sources
          • Sales data
            • Consumer survey data
              • Advertising creative
                • Abbreviations and terms
                  • Abbreviations
                    • Terms
                    • Executive Summary

                      • Sales of remedies sold through food, drug, and mass dip slightly
                        • Market driven by flu/cold incidence, population growth among women, children, elderly
                          • Moderate 2009-10 flu season hurt 2010 sales
                            • One billion colds annually; 50 million allergy sufferers
                              • Female, child, and elderly populations all forecast to increase
                                • Competition from prescription and alternative remedies
                                  • Prescription medicines
                                    • Alternative remedies
                                      • Home remedies and treatment options
                                        • Functional foods: future threat?
                                          • Tablets top the FDMx market
                                            • Drug chains garner most OTC remedy business
                                              • J&J loses 25% in sales after brand recalls
                                                • Children’s remedies, fast-acting medicines top trends
                                                  • Marketing strategies
                                                    • Usage and frequency of use
                                                      • Preventive healthcare measures
                                                        • Ailment-specific treatment
                                                          • Cough, cold, and sore throat
                                                            • Flu
                                                              • Purchase considerations and attitudes toward cold remedies
                                                                • Allergies
                                                                  • Treating allergies and attitudes toward allergy medicine
                                                                    • Impact of race/Hispanic origin
                                                                    • Insights and Opportunities

                                                                      • Tech advances that aid prevention and medication
                                                                        • In-store clinics present an opportunity for retailer/brand integration
                                                                          • Ongoing product recalls spell opportunity for natural ingredients
                                                                            • Allergen-free accommodations: an opening for brand partnership?
                                                                            • Inspire Insights

                                                                                • Inspire Trend: Brand Review
                                                                                • Market Size and Forecast

                                                                                  • Key points
                                                                                    • Moderate 2009-10 flu season and product recalls dampen sales
                                                                                      • Alternative medicines threaten OTC remedy sales
                                                                                        • Private label sales decelerate decline
                                                                                          • Sales and forecast of cold, flu, and allergy remedies
                                                                                            • Figure 1: U.S. FDMx retail sales and forecast of cold, flu, and allergy remedies, at current prices, 2005-15
                                                                                            • Figure 2: U.S. FDMx retail sales and forecast of cold, flu, and allergy remedies, at inflation-adjusted prices, 2005-15
                                                                                          • Fan chart forecast
                                                                                              • Figure 3: FDMx sales and fan chart forecast of cold, flu, and allergy remedies, at current prices, 2005-15
                                                                                            • Walmart sales
                                                                                            • Market Drivers

                                                                                              • Incidence and severity of cold, flu, and allergy
                                                                                                • Figure 4: U.S. seasonal flu severity, 2001-10
                                                                                                • Figure 5: Population of OTC flu remedy users, based on those confirmed to have the flu, by gender, 2011-16
                                                                                              • Women, children, elderly most susceptible to infection
                                                                                                • Children will grow in number between 2011 and 2016
                                                                                                  • Figure 6: U.S. child population, by age, 2006-16
                                                                                                • Women set to increase in the population between 2011 and 2016
                                                                                                  • Figure 7: Female population, by age, 2006-16
                                                                                                • Elderly population expected to grow more than any other demographic
                                                                                                  • Figure 8: U.S. adult population, by age, 2006-16
                                                                                              • Competitive Context

                                                                                                • Rx medicines compete with OTC remedies
                                                                                                  • Alternative remedies also pose a challenge to OTC medicines
                                                                                                    • Home remedies also prevent some sales of OTC medicines
                                                                                                      • Functional food/drinks may be a future competitive threat
                                                                                                      • Segment Performance

                                                                                                        • Key points
                                                                                                          • Tablets lead and post the only FDMx gains between 2009 and 2010
                                                                                                            • Liquids, nasal products drop sales
                                                                                                              • Sales of cold, flu, and allergy remedies, by segment
                                                                                                                • Figure 9: FDMx sales of cold, flu, and allergy remedies, segmented by type, 2009 and 2010
                                                                                                            • Segment Performance—Cold/Allergy/Sinus Tablets

                                                                                                              • Key points
                                                                                                                • Tablets continue to benefit from Rx switches
                                                                                                                  • Private label tablets generate substantial FDMx sales
                                                                                                                    • Sales and forecast of cold/allergy/sinus tablets
                                                                                                                      • Figure 10: U.S. FDMx sales and forecast of cold/allergy/sinus tablets, at current prices, 2005-15
                                                                                                                  • Segment Performance—Cold/Allergy/Sinus Liquids

                                                                                                                    • Key points
                                                                                                                      • Liquids plagued by product recalls while switch products fail to keep pace
                                                                                                                        • Private label decelerates losses
                                                                                                                          • Sales and forecast of cold/allergy/sinus liquids
                                                                                                                            • Figure 11: U.S. FDMx sales and forecast of cold/allergy/sinus liquid, at current prices, 2005-15
                                                                                                                        • Segment Performance—Nasal Products

                                                                                                                          • Key points
                                                                                                                            • Nasal product decline; further losses expected due to Zicam recall
                                                                                                                              • Sales and forecast of nasal products
                                                                                                                                • Figure 12: U.S. FDMx sales and forecast of nasal products, at current prices, 2005-15
                                                                                                                            • Retail Channels

                                                                                                                              • Key points
                                                                                                                                • Drug stores maintain reputation as top healthcare retailer
                                                                                                                                  • Food and mass stores fail to match drug stores
                                                                                                                                    • Sales of cold, flu, and allergy remedies, by channel
                                                                                                                                      • Figure 13: U.S. retail sales of market, by channel, 2009 and 2010
                                                                                                                                  • Retail Channels—Drug Stores

                                                                                                                                    • Key points
                                                                                                                                      • Sales slip in 2010, but drug stores more actively pursue healthcare services
                                                                                                                                        • Drug store sales of cold, flu, and allergy remedies
                                                                                                                                          • Figure 14: U.S. drug store sales of cold, flu, and allergy remedies, at current prices, 2005-10
                                                                                                                                      • Retail Channels—Other FDMx

                                                                                                                                        • Key point
                                                                                                                                          • Food and mass drop sales for the second year in a row
                                                                                                                                            • Other FDMX sales of cold, flu, and allergy remedies
                                                                                                                                              • Figure 15: U.S. other FDMx store sales of cold, flu, and allergy remedies, at current prices, 2010
                                                                                                                                          • Leading Companies

                                                                                                                                            • Key points
                                                                                                                                              • J&J falls dramatically on the heels of product recalls
                                                                                                                                                • Schering-Plough, Reckitt Benckiser, P&G all grow
                                                                                                                                                  • Manufacturer sales of cough, cold, and throat remedies
                                                                                                                                                    • Figure 16: Manufacturer FDMx sales of cold, flu, and allergy remedies in the U.S., 2010 and 2011
                                                                                                                                                • Brand Share—Cold/Allergy/Sinus Tablets

                                                                                                                                                  • Key points
                                                                                                                                                    • J&J still tops tablet segment despite recall troubles
                                                                                                                                                      • Claritin continues its climb for Schering-Plough
                                                                                                                                                        • Some Mucinex brands grow
                                                                                                                                                          • Vicks drives solid growth for P&G
                                                                                                                                                            • Private label capitalizes on tough economy, consumer sentiment
                                                                                                                                                              • Manufacturer and brand sales of cold/allergy/sinus tablets
                                                                                                                                                                • Figure 17: Selected FDMx brand sales and market share of cold/allergy/sinus tablets in the U.S., 2009 and 2010
                                                                                                                                                            • Brand Share—Cold/Allergy/Sinus Liquids

                                                                                                                                                              • Key points
                                                                                                                                                                • Vicks increases give P&G the most growth in the liquids segment
                                                                                                                                                                  • J&J spirals following wide-ranging product recalls
                                                                                                                                                                    • Wyeth increases with Robitussin CF Max and Dimetapp Cold & Cough
                                                                                                                                                                      • Robitussin TV ad
                                                                                                                                                                        • Figure 18: Robitussin relief finder television ad, 2010
                                                                                                                                                                      • Theraflu and Triaminic boost FDMx Novartis sales
                                                                                                                                                                        • Private label grows 19%
                                                                                                                                                                          • Manufacturer and brand sales of cold/allergy/sinus liquids
                                                                                                                                                                            • Figure 19: Selected FDMx brand sales and market share of cold/allergy/sinus liquids in the U.S., 2009 and 2010
                                                                                                                                                                        • Brand Share—Nasal Products

                                                                                                                                                                          • Key points
                                                                                                                                                                            • Nondrug remedies capitalize on negative attention surrounding Zicam
                                                                                                                                                                              • Manufacturer and brand sales of nasal products
                                                                                                                                                                                • Figure 20: Selected FDMx brand sales and market share of nasal products in the U.S., 2009 and 2010
                                                                                                                                                                            • Natural Channel Sales

                                                                                                                                                                                • Key points
                                                                                                                                                                                  • Sales fluctuate in the natural channel
                                                                                                                                                                                    • Sales of cold, flu, and allergy products in the natural channel
                                                                                                                                                                                      • Figure 21: Natural supermarket sales of cold, flu, and allergy products, at current prices, 2009-11
                                                                                                                                                                                      • Figure 22: Natural supermarket sales of cold, flu, and allergy products, at inflation-adjusted prices, 2009-11
                                                                                                                                                                                    • Natural channel sales by segment
                                                                                                                                                                                      • Figure 23: Natural supermarket sales of cold, flu, and allergy products, by segment, 2009 and 2011
                                                                                                                                                                                    • Natural channel sales by product type
                                                                                                                                                                                      • Figure 24: Natural supermarket sales of cold, flu, and allergy products, by product type, 2008 and 2010*
                                                                                                                                                                                    • Leading brands
                                                                                                                                                                                    • Innovation and Innovators

                                                                                                                                                                                      • Cough/cold/flu remedy launches outpace allergy remedy launches
                                                                                                                                                                                        • Figure 25: Number of cough/cold/flu remedy launches vs. number of allergy remedy launches, 2004-10
                                                                                                                                                                                      • Children’s and fast-acting remedies top new product categories
                                                                                                                                                                                        • Figure 26: Cold, flu, and allergy product claims, 2004-10
                                                                                                                                                                                      • Fast-acting remedies
                                                                                                                                                                                        • Children’s remedies
                                                                                                                                                                                          • Homeopathic remedies
                                                                                                                                                                                          • Brands and Marketing Strategies

                                                                                                                                                                                            • Overview of the brand landscape
                                                                                                                                                                                              • Brand analysis: Zyrtec
                                                                                                                                                                                                • Figure 27: Brand analysis of Zyrtec, 2011
                                                                                                                                                                                              • Online initiatives
                                                                                                                                                                                                • Zyrtec TV presence
                                                                                                                                                                                                  • Figure 28: Zyrtec television ad, 2010
                                                                                                                                                                                                • Brand analysis: Claritin
                                                                                                                                                                                                  • Figure 29: Brand analysis of Claritin, 2011
                                                                                                                                                                                                • Online initiatives
                                                                                                                                                                                                  • Claritin TV presence
                                                                                                                                                                                                    • Figure 30: Claritin television ad, 2011
                                                                                                                                                                                                  • Brand analysis: Mucinex
                                                                                                                                                                                                    • Figure 31: Brand analysis of Mucinex, 2011
                                                                                                                                                                                                  • Online initiatives
                                                                                                                                                                                                    • Mucinex TV presence
                                                                                                                                                                                                      • Figure 32: Mucinex television ad, 2011
                                                                                                                                                                                                    • Brand analysis: Vicks
                                                                                                                                                                                                      • Figure 33: Brand analysis of Vicks, 2011
                                                                                                                                                                                                    • Online initiatives
                                                                                                                                                                                                      • Vicks TV presence
                                                                                                                                                                                                        • Figure 34: Vicks television ad, 2010
                                                                                                                                                                                                    • Usage

                                                                                                                                                                                                      • Key points
                                                                                                                                                                                                        • Six in 10 report using remedies
                                                                                                                                                                                                          • Figure 35: Usage of cold, allergy, and sinus remedies, by gender, July 2009-September 2010
                                                                                                                                                                                                        • Respondents aged 35-54 most likely to report using remedies
                                                                                                                                                                                                          • Figure 36: Usage of cold, allergy, and sinus remedies, by age, July 2009-September 2010
                                                                                                                                                                                                      • Types of Cold/Allergy/Sinus Formulations Used

                                                                                                                                                                                                        • Key points
                                                                                                                                                                                                          • Most use 12-hour formulations
                                                                                                                                                                                                            • Figure 37: Types of cold/allergy/sinus formulations used, by gender, July 2009-September 2010
                                                                                                                                                                                                          • Use of four to six-hour formulations decreases with age
                                                                                                                                                                                                            • Figure 38: Types of cold/allergy/sinus formulations used, by age, July 2009-September 2010
                                                                                                                                                                                                        • Brands of Cold/Allergy/Sinus Remedies Used

                                                                                                                                                                                                          • Key points
                                                                                                                                                                                                            • Respondents use Tylenol, Vicks, Benadryl most
                                                                                                                                                                                                              • Figure 39: Summary of top 10 cold/allergy/sinus brands used, by gender, July 2009-September 2010
                                                                                                                                                                                                            • Those aged 18-34 report using Tylenol, Vicks more than older respondents
                                                                                                                                                                                                              • Figure 40: Summary of top 10 cold/allergy/sinus brands used, by age, July 2009-September 2010
                                                                                                                                                                                                            • Use of Sudafed increases with household income
                                                                                                                                                                                                              • Figure 41: Summary of top 10 cold/allergy/sinus brands used, by household income, July 2009-September 2010
                                                                                                                                                                                                          • Usage Frequency

                                                                                                                                                                                                            • Key points
                                                                                                                                                                                                              • Allergy remedies are used most frequently
                                                                                                                                                                                                                • Figure 42: Frequency of use of cold/allergy/sinus remedies, by gender, July 2009-September 2010
                                                                                                                                                                                                              • Those aged 18-24 are the most likely to use allergy meds one to six times per year
                                                                                                                                                                                                                • Figure 43: Frequency of use of cold/allergy/sinus remedies, by age, July 2009-September 2010
                                                                                                                                                                                                            • Preventive Healthcare Measures

                                                                                                                                                                                                              • Key points
                                                                                                                                                                                                                • Hand washing, vitamin regimen top preventive measures
                                                                                                                                                                                                                  • Figure 44: Preventive healthcare measures in past 12 months, by gender, January 2011
                                                                                                                                                                                                                • Older respondents most likely to wash hands frequently, take vitamins
                                                                                                                                                                                                                  • Figure 45: Preventive healthcare measures in past 12 months, by age, January 2011
                                                                                                                                                                                                                • Lowest-income households least likely to take preventive measures
                                                                                                                                                                                                                  • Figure 46: Preventive healthcare measures in past 12 months, by household income, January 2011
                                                                                                                                                                                                              • Cough, Cold, and Flu Sufferers

                                                                                                                                                                                                                • Key points
                                                                                                                                                                                                                  • Cough, cold, sore throat reported more than flu
                                                                                                                                                                                                                    • Figure 47: Cough, cold, and flu experienced in the past 12 months, by gender, January 2011
                                                                                                                                                                                                                  • Incidence is highest among those aged 18-44
                                                                                                                                                                                                                    • Figure 48: Cough, cold, and flu experienced in the past 12 months, by age, January 2011
                                                                                                                                                                                                                • Cough, Cold, Sore Throat Treatment

                                                                                                                                                                                                                  • Key points
                                                                                                                                                                                                                    • Women report more use of OTC, herbal, and home remedies than men
                                                                                                                                                                                                                      • Figure 49: Treating a cough, cold, or sore throat, by gender, January 2011
                                                                                                                                                                                                                    • Senior respondents least likely to use a range of OTC remedies
                                                                                                                                                                                                                      • Figure 50: Treating a cough, cold, or sore throat, by age, January 2011
                                                                                                                                                                                                                  • Flu Treatment

                                                                                                                                                                                                                    • Key points
                                                                                                                                                                                                                      • Respondents use OTC for flu less than for cough/cold/sore throat
                                                                                                                                                                                                                        • Figure 51: Treating flu, by gender, January 2011
                                                                                                                                                                                                                      • Respondents aged 18-34 most likely to use a range of OTC
                                                                                                                                                                                                                        • Figure 52: Treating flu, by age, January 2011
                                                                                                                                                                                                                    • Product Considerations

                                                                                                                                                                                                                      • Key points
                                                                                                                                                                                                                        • Fast acting, long lasting cited as most important product attributes
                                                                                                                                                                                                                            • Figure 53: Importance rating of cough/cold/flu medicine attributes, January 2011
                                                                                                                                                                                                                          • Female respondents appear more concerned with product attributes
                                                                                                                                                                                                                            • Figure 54: Importance rating of cough/cold/flu remedies, by gender, January 2011
                                                                                                                                                                                                                          • Lower-income respondents most likely to cite price as important
                                                                                                                                                                                                                            • Figure 55: Importance rating of cough/cold/flu remedies, by household income, January 2011
                                                                                                                                                                                                                        • Attitudes Toward and Concerns About Cough/Cold/Flu Medicine

                                                                                                                                                                                                                          • Key points
                                                                                                                                                                                                                            • A majority agree that brand name is not always worth the extra price
                                                                                                                                                                                                                              • Figure 56: Attitudes and concerns about medicine, by gender, January 2011
                                                                                                                                                                                                                            • Those aged 55+ most concerned with side effects/negative interactions
                                                                                                                                                                                                                              • Figure 57: Attitudes and concerns about medicine, by age, January 2011
                                                                                                                                                                                                                          • Allergy Sufferers

                                                                                                                                                                                                                            • Key points
                                                                                                                                                                                                                              • Female respondents more likely to report allergies
                                                                                                                                                                                                                                • Figure 58: Allergies experienced in the past 12 months, by gender, January 2011
                                                                                                                                                                                                                              • Nonfood allergies appear to decrease among seniors
                                                                                                                                                                                                                                • Figure 59: Allergies experienced in the past 12 months, by age, January 2011
                                                                                                                                                                                                                            • Treating Nonfood Allergies

                                                                                                                                                                                                                              • Key points
                                                                                                                                                                                                                                • Most respondents use OTC for seasonal and other nonfood allergies
                                                                                                                                                                                                                                  • Figure 60: Overview of allergy treatments used, by allergy type, January 2011
                                                                                                                                                                                                                                • Senior respondents least likely to use OTC for seasonal allergies
                                                                                                                                                                                                                                  • Figure 61: Treating seasonal/outdoor allergies, by age, January 2011
                                                                                                                                                                                                                                • 18-34 most likely to use decongestants for other nonfood allergies
                                                                                                                                                                                                                                  • Figure 62: Treating other nonfood allergies, by age, January 2011
                                                                                                                                                                                                                                • HH income of $50K+ means more OTC and Rx for other nonfood allergies
                                                                                                                                                                                                                                  • Figure 63: Treating other nonfood allergies, by household income, January 2011
                                                                                                                                                                                                                              • Allergy Medicine Side Effects

                                                                                                                                                                                                                                • Key points
                                                                                                                                                                                                                                  • Drowsiness, dry mouth, sleepiness top list of side effects experienced
                                                                                                                                                                                                                                    • Figure 64: Allergy medicine side effects experienced, by gender, January 2011
                                                                                                                                                                                                                                  • Respondents under 45 are the most likely to experience side effects
                                                                                                                                                                                                                                    • Figure 65: Allergy medicine side effects experienced, by age, January 2011
                                                                                                                                                                                                                                • Attitudes Toward and Concerns About Allergy Medicine

                                                                                                                                                                                                                                  • Key points
                                                                                                                                                                                                                                    • A majority applaud Rx-to-OTC allergy remedy switches
                                                                                                                                                                                                                                      • Figure 66: Attitudes and concerns about allergy medicine, by gender, January 2011
                                                                                                                                                                                                                                    • Over-65s most likely to agree private label equivalent to national brands
                                                                                                                                                                                                                                      • Figure 67: Attitudes and concerns about allergy medicine, by age, January 2011
                                                                                                                                                                                                                                  • Impact of Race and Hispanic Origin

                                                                                                                                                                                                                                    • Key points
                                                                                                                                                                                                                                      • Black respondents most likely to take preventive measure
                                                                                                                                                                                                                                        • Figure 68: Preventive healthcare measures in past 12 months, by race/Hispanic origin, January 2011
                                                                                                                                                                                                                                      • Cough, sore throat and flu experienced in past year
                                                                                                                                                                                                                                        • Figure 69: Cough, cold, and flu experienced in the past 12 months, by race/Hispanic origin, January 2011
                                                                                                                                                                                                                                      • Blacks most likely to use Rx as well as a range of OTC remedies
                                                                                                                                                                                                                                        • Figure 70: Treating a cough, cold or sore throat, by race/Hispanic origin, January 2011
                                                                                                                                                                                                                                      • Blacks, Hispanics report a range of important purchase considerations
                                                                                                                                                                                                                                        • Figure 71: Importance rating of cough/cold/flu remedies, by race/Hispanic origin, January 2011
                                                                                                                                                                                                                                      • Blacks most likely to worry about side effects, negative interactions
                                                                                                                                                                                                                                        • Figure 72: Attitudes and concerns about medicine, by race/Hispanic origin, January 2011
                                                                                                                                                                                                                                      • Blacks most likely to use Rx as well as OTC decongestants
                                                                                                                                                                                                                                        • Figure 73: Treating seasonal/outdoor allergies, by race/Hispanic origin, January 2011
                                                                                                                                                                                                                                      • Blacks, Hispanics more likely to have concerns about allergy remedies
                                                                                                                                                                                                                                        • Figure 74: Attitudes and concerns about allergy medicine, by race/Hispanic origin, January 2011
                                                                                                                                                                                                                                    • Cluster Analysis

                                                                                                                                                                                                                                        • Cluster 1: Natural Experimenters
                                                                                                                                                                                                                                          • Characteristics
                                                                                                                                                                                                                                            • Opportunity
                                                                                                                                                                                                                                              • Cluster 2: Concerned Moderates
                                                                                                                                                                                                                                                • Characteristics
                                                                                                                                                                                                                                                  • Opportunity
                                                                                                                                                                                                                                                    • Cluster 3: Passive Sufferers
                                                                                                                                                                                                                                                      • Characteristics
                                                                                                                                                                                                                                                        • Opportunity
                                                                                                                                                                                                                                                          • Characteristic tables
                                                                                                                                                                                                                                                            • Figure 75: Cold, flu, and allergy remedies consumer clusters, January 2011
                                                                                                                                                                                                                                                            • Figure 76: Cough, cold, flu, and allergies experienced in the past 12 months, by clusters, January 2011
                                                                                                                                                                                                                                                            • Figure 77: Preventive healthcare measures in past 12 months, by clusters, January 2011
                                                                                                                                                                                                                                                            • Figure 78: Treating a cough, cold, or sore throat, by clusters, January 2011
                                                                                                                                                                                                                                                            • Figure 79: Importance rating of cough/cold/flu remedies, by clusters, January 2011
                                                                                                                                                                                                                                                            • Figure 80: Attitudes and concerns about medicine, by clusters, January 2011
                                                                                                                                                                                                                                                          • Demographic tables:
                                                                                                                                                                                                                                                            • Figure 81: Cold, flu, and allergy remedies consumer clusters by gender, January 2011
                                                                                                                                                                                                                                                            • Figure 82: Cold, flu, and allergy remedies consumer clusters by age, January 2011
                                                                                                                                                                                                                                                            • Figure 83: Cold, flu, and allergy remedies consumer clusters by household income, January 2011
                                                                                                                                                                                                                                                            • Figure 84: Cold, flu, and allergy remedies consumer clusters by race/Hispanic origin, January 2011
                                                                                                                                                                                                                                                          • Cluster methodology
                                                                                                                                                                                                                                                          • Custom Consumer Groups

                                                                                                                                                                                                                                                              • Key points
                                                                                                                                                                                                                                                                • Midwestern respondents most likely to use OTC for cough/cold/sore throat
                                                                                                                                                                                                                                                                  • Figure 85: Treating a cough, cold, or sore throat, by region, January 2011
                                                                                                                                                                                                                                                                • Presence of children raises concerns about cough/cold/sore throat remedies
                                                                                                                                                                                                                                                                    • Figure 86: Attitudes and concerns about medicine, by presence of children, January 2011
                                                                                                                                                                                                                                                                • SymphonyIRI Group Builders Panel Data

                                                                                                                                                                                                                                                                    • Cold/allergy/sinus tablets
                                                                                                                                                                                                                                                                      • Consumer insights on key purchase measures
                                                                                                                                                                                                                                                                        • Brand map
                                                                                                                                                                                                                                                                          • Figure 87: Brand map, selected brands of cold/allergy/sinus tablets buying rate by household penetration, 52 weeks ending June 27, 2010
                                                                                                                                                                                                                                                                        • Brand leader characteristics
                                                                                                                                                                                                                                                                          • Key purchase measures
                                                                                                                                                                                                                                                                            • Figure 88: Key purchase measures for the top brands of cold/allergy/sinus tablets, by household penetration, 52 weeks ending June 27, 2010
                                                                                                                                                                                                                                                                          • Cold/allergy/sinus liquids
                                                                                                                                                                                                                                                                            • Consumer insights on key purchase measures
                                                                                                                                                                                                                                                                              • Brand map
                                                                                                                                                                                                                                                                                • Figure 89: Brand map, selected brands of cold/allergy/sinus liquids buying rate by household penetration, 52 weeks ending June 27, 2010
                                                                                                                                                                                                                                                                              • Brand leader characteristics
                                                                                                                                                                                                                                                                                • Key purchase measures
                                                                                                                                                                                                                                                                                  • Figure 90: Key purchase measures for the top brands of cold/allergy/sinus liquids, by household penetration, 52 weeks ending June 27, 2010
                                                                                                                                                                                                                                                                              • Appendix—Other Useful Consumer Tables—Household Income

                                                                                                                                                                                                                                                                                • Cough, cold, sore throat and flu
                                                                                                                                                                                                                                                                                  • Figure 91: Cough, cold, and flu experienced in the past 12 months, by household income, January 2011
                                                                                                                                                                                                                                                                                  • Figure 92: Treating a cough, cold, or sore throat, by household income, January 2011
                                                                                                                                                                                                                                                                                  • Figure 93: Treating flu, by household income, January 2011
                                                                                                                                                                                                                                                                                  • Figure 94: Attitudes and concerns about medicine, by household income, January 2011
                                                                                                                                                                                                                                                                                • Allergy sufferers
                                                                                                                                                                                                                                                                                  • Figure 95: Allergies experienced in the past 12 months, by household income, January 2011
                                                                                                                                                                                                                                                                                  • Figure 96: Treating seasonal/outdoor allergies, by household income, January 2011
                                                                                                                                                                                                                                                                                  • Figure 97: Allergy medicine side effects experienced, by household income, January 2011
                                                                                                                                                                                                                                                                                  • Figure 98: Attitudes and concerns about allergy medicine, by household income, January 2011
                                                                                                                                                                                                                                                                              • Appendix—SymphonyIRI Builders Panel Data Definitions

                                                                                                                                                                                                                                                                                  • SymphonyIRI Consumer Network Metrics
                                                                                                                                                                                                                                                                                  • Appendix—Trade Associations

                                                                                                                                                                                                                                                                                    Companies Covered

                                                                                                                                                                                                                                                                                    • American Medical Association (AMA)
                                                                                                                                                                                                                                                                                    • Association of Convenience Stores
                                                                                                                                                                                                                                                                                    • Bayer Corporation
                                                                                                                                                                                                                                                                                    • Chain Drug Marketing Association
                                                                                                                                                                                                                                                                                    • Consumer Healthcare Products Association (CHPA)
                                                                                                                                                                                                                                                                                    • CVS Caremark Corporation
                                                                                                                                                                                                                                                                                    • Food and Drug Administration
                                                                                                                                                                                                                                                                                    • GlaxoSmithKline (USA)
                                                                                                                                                                                                                                                                                    • Hyatt Corporation
                                                                                                                                                                                                                                                                                    • Institute of Food Technologists (IFT)
                                                                                                                                                                                                                                                                                    • Johnson & Johnson
                                                                                                                                                                                                                                                                                    • McNeil Consumer & Specialty Pharmaceuticals
                                                                                                                                                                                                                                                                                    • Novartis Pharmaceuticals Corporation
                                                                                                                                                                                                                                                                                    • Pfizer Inc
                                                                                                                                                                                                                                                                                    • Pharmavite LLC
                                                                                                                                                                                                                                                                                    • Procter & Gamble Company (The)
                                                                                                                                                                                                                                                                                    • Procter & Gamble USA
                                                                                                                                                                                                                                                                                    • Reckitt Benckiser USA
                                                                                                                                                                                                                                                                                    • Rite Aid Corporation
                                                                                                                                                                                                                                                                                    • Safeway Inc
                                                                                                                                                                                                                                                                                    • The National Institute of Allergy and Infectious Diseases (NIAID)
                                                                                                                                                                                                                                                                                    • U.S. Bureau of Labor Statistics
                                                                                                                                                                                                                                                                                    • U.S. Consumer Product Safety Commission
                                                                                                                                                                                                                                                                                    • Walgreen Co
                                                                                                                                                                                                                                                                                    • World Health Organization
                                                                                                                                                                                                                                                                                    • Wyeth

                                                                                                                                                                                                                                                                                    Cold, Flu and Allergy Remedies - US - May 2011

                                                                                                                                                                                                                                                                                    £3,199.84 (Excl.Tax)